Loading…
Product type
Erlotinib Hydrochloride is a targeted therapy used primarily in the treatment of certain types of cancer, particularly non-small cell lung cancer and pancreatic cancer. It functions as an epidermal growth factor receptor (EGFR) inhibitor, blocking the signals that promote cancer cell growth and division. This compound is typically available in a crystalline powder form and is soluble in water, making it suitable for various pharmaceutical formulations.
| Chemical formula | C22H24ClN3O4 |
| Molecular weight | 393.89 g/mol |
| Purity | Typically > 98% |
| Form | Crystalline powder |
| Solubility | Soluble in water and organic solvents |
When selecting Erlotinib Hydrochloride, buyers should consider the required purity levels, as pharmaceutical applications often necessitate high purity (typically over 98%). It is also essential to specify the desired form, such as crystalline powder, and any specific solubility requirements. Certifications such as Good Manufacturing Practice (GMP) compliance may be necessary, depending on the intended use. Additionally, buyers should indicate the quantity needed for their applications, as bulk orders may be subject to different pricing and lead times.
Get quotes for Erlotinib Hydrochloride
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer.
It is typically taken orally in tablet form.
Common side effects include rash, diarrhea, and nausea.
No, it is specifically effective for cancers with EGFR mutations.
Patients should be monitored for side effects and response to therapy.
Yes, it may be used in combination with chemotherapy or other targeted therapies.